Personalized approaches to bronchiectasis

References

• Martínez-García M, Máiz L, Olveira C, et al. Spanish guidelines on the evaluation and diagnosis of bronchiectasis in adults. Arch Bronconeumol. 2018 Feb;54(2):79–87.
   PubMed Web of Science ®Google Scholar
• Hill AT, Sullivan AL, Chalmers JD, et al. British thoracic society guideline for bronchiectasis in adults. Thorax. 2019 1;74(Suppl 1):1–69.
   Web of Science ®Google Scholar
• Polverino E, Goeminne PC, McDonnell MJ, et al. European respiratory society guidelines for the management of adult bronchiectasis. Eur Respir J. 2017 09;50:3.
   Web of Science ®Google Scholar
• Araújo D, Shteinberg M, Aliberti S, et al. Standardised classification of the aetiology of bronchiectasis using an objective algorithm. Eur Respir J. 2017 12;50:6.
   Web of Science ®Google Scholar
• Martinez-Garcia MA, Polverino E, Aksamit T. Bronchiectasis and chronic airway disease: it is not just about asthma and COPD. Chest. 2018 10;154(4):737–739.
   PubMed Web of Science ®Google Scholar
• Guan WJ, Han XR, de la Rosa-carrillo D, et al. The significant global economic burden of bronchiectasis: a pending matter. Eur Respir J. 2019 02;53:2.
   Web of Science ®Google Scholar
• Martínez-García MA, Olveira C, Máiz L, et al. Bronchiectasis: a complex, heterogeneous disease. Arch Bronconeumol. 2019 08; 55(8): 427–433.
   PubMed Web of Science ®Google Scholar
• Martinez-Garcia MA, Agustí A. Heterogeneity and complexity in bronchiectasis: A pending challenge. Arch Bronconeumol. 2019 04;55(4):187–188.
   PubMed Web of Science ®Google Scholar
• Martinez-Garcia MA, Aksamit TR, Agusti A. Clinical fingerprinting: a way to address the complexity and heterogeneity of bronchiectasis in practice. Am J Respir Crit Care Med. 2020 01;201(1):14–19.
   PubMed Web of Science ®Google Scholar
• Martínez-García M, de Gracia J, Vendrell Relat M, et al. Multidimensional approach to non-cystic fibrosis bronchiectasis: the FACED score. Eur Respir J. 2014 May;43(5):1357–1367.
   PubMed Web of Science ®Google Scholar
• Chalmers JD, Goeminne P, Aliberti S, et al. The bronchiectasis severity index. An international derivation and validation study. Am J Respir Crit Care Med. 2014 Mar 189;5:576–585.
   PubMed Web of Science ®Google Scholar
• Gao YH, Guan WJ, Liu SX, et al. Aetiology of bronchiectasis in adults: A systematic literature review. Respirology. 2016 11; 21(8): 1376–1383.
   PubMed Web of Science ®Google Scholar
• Chandrasekaran R, Mac Aogáin M, Chalmers JD, et al. Geographic variation in the aetiology, epidemiology and microbiology of bronchiectasis. BMC Pulm Med. 2018 May;18(1):83.
   PubMedGoogle Scholar
• Olveira C, Padilla A, Martínez-García M, et al. Etiology of bronchiectasis in a cohort of 2047 patients. an analysis of the Spanish historical bronchiectasis registry. Arch Bronconeumol. 2017 Jul;53(7):366–374.
   PubMed Web of Science ®Google Scholar
• De la Rosa D, Martínez-Garcia MA, Giron RM, et al. Clinical impact of chronic obstructive pulmonary disease on non-cystic fibrosis bronchiectasis. A study on 1,790 patients from the Spanish bronchiectasis historical registry. PLoS One. 2017;12(5):e0177931.
   PubMed Web of Science ®Google Scholar
• Martinez-García MA, Villa C, Dobarganes Y, et al. RIBRON: the Spanish online bronchiectasis registry. characterization of the first 1912 patients. Arch Bronconeumol. 2021 Jan;57(1):28-35.
   Google Scholar
• Lonni S, Chalmers JD, Goeminne PC, et al. Etiology of non-cystic fibrosis bronchiectasis in adults and its correlation to disease severity. Ann Am Thorac Soc. 2015;Dec;12(12):1764–1770.
   PubMed Web of Science ®Google Scholar
• Chalmers JD, Crichton M, Goeminne PC, et al. The European multicentre bronchiectasis audit and research collaboration (EMBARC): experiences from a successful ERS clinical research collaboration. Breathe (Sheff). 2017 Sep;13(3):180–192.
   PubMedGoogle Scholar
• Dhar R, Singh S, Talwar D, et al. Bronchiectasis in India: results from the European multicentre bronchiectasis audit and research collaboration (EMBARC) and respiratory research network of India registry. Lancet Glob Health. 2019 09; 7(9): e1269–e79.
   PubMed Web of Science ®Google Scholar
• Huang HY, Chung FT, Lo CY, et al. Etiology and characteristics of patients with bronchiectasis in Taiwan: a cohort study from 2002 to 2016. BMC Pulm Med. 2020 Feb;20(1):45.
   PubMed Web of Science ®Google Scholar
• Aksamit TR, O’Donnell AE, Barker A, et al. adult patients with bronchiectasis: a first look at the US bronchiectasis research registry. Chest. 2017 05; 151(5): 982–992.
   PubMed Web of Science ®Google Scholar
• Buscot M, Pottier H, Marquette CH, et al. Phenotyping adults with non-cystic fibrosis bronchiectasis: A 10-year cohort study in a French regional university hospital center. Respiration. 2016;92(1):1–8.
   PubMed Web of Science ®Google Scholar
• Poeta M, Maglione M, Borrelli M, et al. Non-cystic fibrosis bronchiectasis in children and adolescents: neglected and emerging issues. Pediatr Neonatol. 2020 06; 61(3): 255–262.
   PubMed Web of Science ®Google Scholar
• Edwards EA, Asher MI, Byrnes CA. Paediatric bronchiectasis in the twenty-first century: experience of a tertiary children’s hospital in New Zealand. J Paediatr Child Health. 2003 Mar;39(2):111–117.
   PubMed Web of Science ®Google Scholar
• Evans SA, Turner SM, Bosch BJ, et al. Lung function in bronchiectasis: the influence of Pseudomonas aeruginosa. Eur Respir J. 1996 Aug;9(8):1601–1604.
   PubMed Web of Science ®Google Scholar
• McDonnell MJ, Jary HR, Perry A, et al. Non cystic fibrosis bronchiectasis: A longitudinal retrospective observational cohort study of Pseudomonas persistence and resistance. Respir Med. 2015 Jun;109(6):716–726.
   PubMed Web of Science ®Google Scholar
• Hernández C, Abreu J, Jiménez A, et al. [Pulmonary function and quality of life in relation to bronchial colonization in adults with bronchiectasis not caused by cystic fibrosis]. Med Clin (Barc). 2002 Feb;118(4):130–134.
   PubMed Web of Science ®Google Scholar
• Martínez-García MA, Soler-Cataluña JJ, Perpiñá-Tordera M, et al. Factors associated with lung function decline in adult patients with stable non-cystic fibrosis bronchiectasis. Chest. 2007 Nov;132(5):1565–1572.
   PubMed Web of Science ®Google Scholar
• Martinez-García MA, Oscullo G, Posadas T, et al. Pseudomonas aeruginosa and lung function decline in patients with bronchiectasis. Clin Microbiol Infect. 2020 Apr. DOI:10.1016/j.cmi.2020.04.007.
   PubMed Web of Science ®Google Scholar
• Chalmers JD, Aliberti S, Filonenko A, et al. Characterization of the “Frequent Exacerbator Phenotype” in Bronchiectasis. Am J Respir Crit Care Med. 2018 06; 197(11): 1410–1420.
   PubMed Web of Science ®Google Scholar
• Martinez-Garcia M, Athanazio R, Gramblicka G, et al. Prognostic value of frequent exacerbations in bronchiectasis: the relationship with disease severity. Arch Bronconeumol. 2019 02; 55(2): 81–87.
   PubMed Web of Science ®Google Scholar
• Webb WR. High resolution lung CT. English. Philadelphia: Lippincott Williams & Wilkins,US; 2000.
   Google Scholar
• Polverino E, Dimakou K, Hurst J, et al. The overlap between bronchiectasis and chronic airway diseases: state of the art and future directions. Eur Respir J. 2018 09;52:3.
   Web of Science ®Google Scholar
• Reiff DB, Wells AU, Carr DH, et al. CT findings in bronchiectasis: limited value in distinguishing between idiopathic and specific types. AJR Am J Roentgenol. 1995 Aug;165(2):261–267.
   PubMed Web of Science ®Google Scholar
• Bhalla M, Turcios N, Aponte V, et al. Cystic fibrosis: scoring system with thin-section CT. Radiology. 1991 Jun;179(3):783–788.
   PubMed Web of Science ®Google Scholar
• McDonnell MJ, Ahmed M, Das J, et al. Patterns of disease in patients with middle-lobe predominant bronchiectasis. Respiration. 2017;93(6):406–414.
   PubMed Web of Science ®Google Scholar
• Onen ZP, Gulbay BE, Sen E, et al. Analysis of the factors related to mortality in patients with bronchiectasis. Respir Med. 2007 Jul;101(7):1390–1397.
   PubMed Web of Science ®Google Scholar
• Loebinger MR, Wells AU, Hansell DM, et al. Mortality in bronchiectasis: a long-term study assessing the factors influencing survival. Eur Respir J. 2009 Oct;34(4):843–849.
   PubMed Web of Science ®Google Scholar
• Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383.
   PubMedGoogle Scholar
• McDonnell MJ, Aliberti S, Goeminne PC, et al. Comorbidities and the risk of mortality in patients with bronchiectasis: an international multicentre cohort study. Lancet Respir Med. 2016 12; 4(12): 969–979.
   PubMed Web of Science ®Google Scholar
• Athanazio R, Pereira MC, Gramblicka G, et al. Latin America validation of FACED score in patients with bronchiectasis: an analysis of six cohorts. BMC Pulm Med. 2017 Apr;17(1):73.
   PubMed Web of Science ®Google Scholar
• de la Rosa Carrillo D, Athanazio R, Girón Moreno RM, et al. The annual prognostic ability of FACED and E-FACED scores to predict mortality in patients with bronchiectasis. ERJ Open Res. 2018 Jan;4:1.
   Google Scholar
• Stockley RA, Halpin DMG, Celli BR, et al. Chronic obstructive pulmonary disease biomarkers and their interpretation. Am J Respir Crit Care Med. 2019 05;199(10):1195–1204.
   PubMed Web of Science ®Google Scholar
• Murray MP, Pentland JL, Turnbull K, et al. Sputum colour: a useful clinical tool in non-cystic fibrosis bronchiectasis. Eur Respir J. 2009 Aug;34(2):361–364.
   PubMed Web of Science ®Google Scholar
• Posadas T, Oscullo G, Zaldivar E, et al. C-reactive protein concentration in steady-state bronchiectasis: prognostic value of future severe exacerbations. Data from the Spanish registry of bronchiectasis (RIBRON). Arch Bronconeumol. 2021 Jan;57(1):21-27.
   Google Scholar
• Chalmers JD, Moffitt KL, Suarez-Cuartin G, et al. Neutrophil elastase activity is associated with exacerbations and lung function decline in bronchiectasis. Am J Respir Crit Care Med. 2017 05; 195(10): 1384–1393.
   PubMed Web of Science ®Google Scholar
• Oscullo Yepez G, Sierra-Párraga JM, Posadas Blazquez T, et al. Towards precision medicine in bronchiectasis: what is the role of neutrophilic elastase determination? Eur Respir J. 2019 Jun;53:6.
   Web of Science ®Google Scholar
• Wilson R, Aksamit T, Aliberti S, et al. Challenges in managing Pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis. Respir Med. 2016 08;117:179–189.
   PubMed Web of Science ®Google Scholar
• Finch S, McDonnell MJ, Abo-Leyah H, et al. A comprehensive analysis of the impact of Pseudomonas aeruginosa colonization on prognosis in adult bronchiectasis. Ann Am Thorac Soc. 2015 Nov;12(11):1602–1611.
   PubMed Web of Science ®Google Scholar
• Araújo D, Shteinberg M, Aliberti S, et al. The independent contribution of. Eur Respir J. 2018 02;51:2.
   Web of Science ®Google Scholar
• Martinez-García MA. infection and exacerbations in bronchiectasis: more questions than answers. Eur Respir J. 2018 02;51:2.
   Web of Science ®Google Scholar
• Martinez-Garcia MA, Athanazio RA, Girón R, et al. Predicting high risk of exacerbations in bronchiectasis: the E-FACED score. Int J Chron Obstruct Pulmon Dis. 2017;12:275–284.
   PubMed Web of Science ®Google Scholar
• Tino G. Bronchiectasis: phenotyping an Orphan Disease. Am J Respir Crit Care Med. 2018 06;197(11):1371–1373.
   PubMed Web of Science ®Google Scholar
• Qi Q, Li T, Li JC, et al. Association of body mass index with disease severity and prognosis in patients with non-cystic fibrosis bronchiectasis. Braz J Med Biol Res. 2015 Aug;48(8):715–724.
   PubMed Web of Science ®Google Scholar
• Martínez-García M, Máiz L, Olveira C, et al. Spanish guidelines on treatment of bronchiectasis in adults. Arch Bronconeumol. 2018 Feb;54(2):88–98.
   PubMed Web of Science ®Google Scholar
• Chalmers JD. Bronchiectasis: phenotyping a complex disease. COPD. 2017 Mar;14(sup1):S12–S18.
   PubMedGoogle Scholar
• Olveira G, Olveira C, Gaspar I, et al. Fat-free mass depletion and inflammation in patients with bronchiectasis. J Acad Nutr Diet. 2012 Dec;112(12):1999–2006.
   PubMed Web of Science ®Google Scholar
• Martínez-García MA, Perpiñá-Tordera M, Soler-Cataluña JJ, et al. Dissociation of lung function, dyspnea ratings and pulmonary extension in bronchiectasis. Respir Med. 2007 Nov;101(11):2248–2253.
   PubMed Web of Science ®Google Scholar
• Martínez-García MA, Perpiñá-Tordera M, Román-Sánchez P, et al. Quality-of-life determinants in patients with clinically stable bronchiectasis. Chest. 2005 Aug;128(2):739–745.
   PubMed Web of Science ®Google Scholar
• Padilla A, Olveira G, Olveira C, et al. [Validity and reliability of the St George’s respiratory questionnaire in adults with cystic fibrosis]. Arch Bronconeumol. 2007 Apr;43(4):205–211.
   PubMed Web of Science ®Google Scholar
• Olveira G, Olveira C, Gaspar I, et al. [Validation of the Spanish version of the revised cystic fibrosis quality of life questionnaire in adolescents and adults (CFQR 14+ Spain)]. Arch Bronconeumol. 2010 Apr;46(4):165–175.
   PubMed Web of Science ®Google Scholar
• Wilson CB, Jones PW, O’Leary CJ, et al. Effect of sputum bacteriology on the quality of life of patients with bronchiectasis. Eur Respir J. 1997 Aug;10(8):1754–1760.
   PubMed Web of Science ®Google Scholar
• Courtney JM, Kelly MG, Watt A, et al. Quality of life and inflammation in exacerbations of bronchiectasis. Chron Respir Dis. 2008;5(3):161–168.
   PubMedGoogle Scholar
• Chan SL, Chan-Yeung MM, Ooi GC, et al. Validation of the Hong Kong Chinese version of the St. George Respiratory Questionnaire in patients with bronchiectasis. Chest. 2002 Dec;122(6):2030–2037.
   PubMed Web of Science ®Google Scholar
• Bulcun E, Arslan M, Ekici A, et al. Quality of Life and bronchial hyper-responsiveness in subjects with bronchiectasis: validation of the Seattle obstructive lung disease questionnaire in bronchiectasis. Respir Care. 2015 Nov;60(11):1616–1623.
   PubMed Web of Science ®Google Scholar
• Olveira C, Olveira G, Gaspar I, et al. Depression and anxiety symptoms in bronchiectasis: associations with health-related quality of life. Qual Life Res. 2013 Apr;22(3):597–605.
   PubMed Web of Science ®Google Scholar
• Olveira C, Olveira G, Espildora F, et al. Mediterranean diet is associated on symptoms of depression and anxiety in patients with bronchiectasis. Gen Hosp Psychiatry. 2014 May-Jun;36(3):277–283.
   PubMed Web of Science ®Google Scholar
• Ware JE, Kosinski M, Keller SD, et al. SF-36 physical and mental health summary scales: a user’s manual. Boston, Mass: Health Institute, New England Medical Center; 1994. English.
   Google Scholar
• Jones PW, Quirk FH, Baveystock CM, et al. A self-complete measure of health status for chronic airflow limitation. The St. George’s Respiratory Questionnaire. Am Rev Respir Dis. 1992 Jun;145(6):1321–1327.
   PubMed Web of Science ®Google Scholar
• Martínez García MA, Perpiñá Tordera M, Román Sánchez P, et al. [Internal consistency and validity of the Spanish version of the St. George’s respiratory questionnaire for use in patients with clinically stable bronchiectasis]. Arch Bronconeumol. 2005 Mar;41(3):110–117.
   PubMed Web of Science ®Google Scholar
• Jones PW, Quirk FH, Baveystock CM. The St George’s Respiratory Questionnaire. Respir Med. 1991 Sep;85(Suppl B):25–31. discussion 33-7.
   PubMed Web of Science ®Google Scholar
• De la Rosa Carrillo D, Olveira C, García-Clemente M, et al. COPD assessment test in bronchiectasis: minimum clinically important difference and psychometric validation: a prospective study. Chest. 2020 Apr;157(4):824–833.
   PubMed Web of Science ®Google Scholar
• Singh D, Agusti A, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019. Eur Respir J. 2019 05;53:5.
   Web of Science ®Google Scholar
• Finch S, Laska IF, Abo-Leyah H, et al. Validation of the COPD Assessment Test (CAT) as an outcome measure in bronchiectasis. Chest. 2020 Apr;157(4):815–823.
   PubMed Web of Science ®Google Scholar
• Quittner AL, O’Donnell AE, Salathe MA, et al. Quality of life questionnaire-bronchiectasis: final psychometric analyses and determination of minimal important difference scores. Thorax. 2015 Jan;70(1):12–20.
   PubMed Web of Science ®Google Scholar
• Murray MP, Govan JR, Doherty CJ, et al. A randomized controlled trial of nebulized gentamicin in non-cystic fibrosis bronchiectasis. Am J Respir Crit Care Med. 2011 Feb;183(4):491–499.
   PubMed Web of Science ®Google Scholar
• Muñoz G, Buxó M, de Gracia J, et al. Validation of a Spanish version of the Leicester cough questionnaire in non-cystic fibrosis bronchiectasis. Chron Respir Dis. 2016 May;13(2):128–136.
   PubMed Web of Science ®Google Scholar
• Spinou A, Siegert RJ, Guan WJ, et al. The development and validation of the bronchiectasis health questionnaire. Eur Respir J. 2017 05;49:5.
   Web of Science ®Google Scholar
• Nucci MCNM, Fernandes FLA, Salge JM, et al., Characterization of the severity of dyspnea in patients with bronchiectasis: correlation with clinical, functional, and tomographic aspects. J Bras Pneumol. 46(5): e20190162. 2020.
   PubMed Web of Science ®Google Scholar
• Murray MP, Turnbull K, MacQuarrie S, et al. Validation of the Leicester Cough Questionnaire in non-cystic fibrosis bronchiectasis. Eur Respir J. 2009 Jul;34(1):125–131.
   PubMed Web of Science ®Google Scholar
• Birring SS, Birring SS, Prudon B, Carr AJ, et al. Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ). Thorax. 2003 Apr;58(4):339–343.
   PubMed Web of Science ®Google Scholar
• Martinez-Vergara A, Girón-Moreno RM, Martínez-García MA. Dyspnea in bronchiectasis: a complex symptom of a complex disease. J Bras Pneumol. 2020 Sep;46(5):e20200281.
   PubMedGoogle Scholar
• Mahler DA, Wells CK. Evaluation of clinical methods for rating dyspnea. Chest. 1988 Mar;93(3):580–586.
   PubMed Web of Science ®Google Scholar
• Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983 Jun;67(6):361–370.
   PubMed Web of Science ®Google Scholar
• Herrero MJ, Blanch J, Peri JM, et al. A validation study of the hospital anxiety and depression scale (HADS) in a Spanish population. Gen Hosp Psychiatry. 2003 Jul-Aug;25(4):277–283.
   PubMed Web of Science ®Google Scholar
• O’Leary CJ, Wilson CB, Hansell DM, et al. Relationship between psychological well-being and lung health status in patients with bronchiectasis. Respir Med. 2002 Sep;96(9):686–692.
   PubMed Web of Science ®Google Scholar
• Gao YH, Guan WJ, Zhu YN, et al. Anxiety and depression in adult outpatients with bronchiectasis: associations with disease severity and health-related quality of life. Clin Respir J. 2018 Apr;12(4):1485–1494.
   PubMed Web of Science ®Google Scholar
• Boussoffara L, Boudawara N, Gharsallaoui Z, et al. [Anxiety-depressive disorders and bronchiectasis]. Rev Mal Respir. 2014 Mar;31(3):230–236.
   PubMed Web of Science ®Google Scholar
• Quittner AL, Abbott J, Georgiopoulos AM, et al. International committee on mental health in cystic fibrosis: cystic fibrosis foundation and European cystic fibrosis society consensus statements for screening and treating depression and anxiety. Thorax. 2016 Jan;71(1):26–34.
   PubMed Web of Science ®Google Scholar
• Anwar GA, McDonnell MJ, Worthy SA, et al. Phenotyping adults with non-cystic fibrosis bronchiectasis: a prospective observational cohort study. Respir Med. 2013 Jul;107(7):1001–1007.
   PubMed Web of Science ®Google Scholar
• Aliberti S, Lonni S, Dore S, et al. Clinical phenotypes in adult patients with bronchiectasis. Eur Respir J. 2016 Apr;47(4):1113–1122.
   PubMed Web of Science ®Google Scholar
• Guan WJ, Jiang M, Gao YH, et al. Unsupervised learning technique identifies bronchiectasis phenotypes with distinct clinical characteristics. Int J Tuberc Lung Dis. 2016 Mar;20(3):402–410.
   PubMed Web of Science ®Google Scholar
• Martínez-García M, Vendrell M, Girón R, et al. The multiple faces of non-cystic fibrosis bronchiectasis. a cluster analysis approach. Ann Am Thorac Soc. 2016 09;13(9):1468–1475.
   PubMed Web of Science ®Google Scholar
• Du Q, Jin J, Liu X, et al. Bronchiectasis as a comorbidity of chronic obstructive pulmonary disease: a systematic review and meta-analysis. PLoS One. 2016;11(3):e0150532.
   PubMed Web of Science ®Google Scholar
• van Dijk BCP, Svedsater H, Heddini A, et al. Relationship between the asthma control test (ACT) and other outcomes: a targeted literature review. BMC Pulm Med. 2020 Apr;20(1):79.
   PubMed Web of Science ®Google Scholar
• Prevoo ML, van ‘T Hof MA, Kuper HH, et al. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 1995 Jan;38(1):44–48.
   PubMed Web of Science ®Google Scholar
• Boaventura R, Sibila O, Agusti A,,, et al. Treatable traits in bronchiectasis. Eur Respir J. 09, 2018;52:3.
   Web of Science ®Google Scholar
• Agusti A, Bel E, Thomas M, et al. Treatable traits: toward precision medicine of chronic airway diseases. Eur Respir J. 2016 Feb;47(2):410–419.
   PubMed Web of Science ®Google Scholar
• Chalmers JD, Haworth CS, Metersky ML, et al. Phase 2 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis. N Engl J Med. 2020 Sep;383(22):2127–2137.
   PubMed Web of Science ®Google Scholar
• Bedi P, Chalmers JD, Graham C, et al. A randomized controlled trial of atorvastatin in patients with bronchiectasis infected with pseudomonas aeruginosa: a proof of concept study. Chest. 2017 08; 152(2): 368–378.
   PubMed Web of Science ®Google Scholar
• Lucas JS, Davis SD, Omran H, et al. Primary ciliary dyskinesia in the genomics age. Lancet Respir Med. 2020 02; 8(2): 202–216.
   PubMed Web of Science ®Google Scholar
• Wu J, Chen J, Tian ZQ, et al. Clinical manifestations and genetic analysis of 17 patients with autosomal dominant hyper-ige syndrome in mainland china: new reports and a literature review. J Clin Immunol. 2017 Feb;37(2):166–179.
   PubMed Web of Science ®Google Scholar
• Hoyos-Bachiloglu R, Chou J. Autoimmunity and immunodeficiency. Curr Opin Rheumatol. 2020 03;32(2):168–174.
   PubMed Web of Science ®Google Scholar
• Overton NLD, Denning DW, Bowyer P; Overton NL, Denning DW, Bowyer P, et al. Genetic susceptibility to allergic bronchopulmonary aspergillosis in asthma: a genetic association study. Allergy Asthma Clin Immunol. 2016;12:47.
   PubMed Web of Science ®Google Scholar
• Cox MJ, Turek EM, Hennessy C, et al. Longitudinal assessment of sputum microbiome by sequencing of the 16S rRNA gene in non-cystic fibrosis bronchiectasis patients. PLoS One. 2017;12(2):e0170622.
   PubMed Web of Science ®Google Scholar
• Rogers GB, Zain NM, Bruce KD, et al. A novel microbiota stratification system predicts future exacerbations in bronchiectasis. Ann Am Thorac Soc. 2014 May;11(4):496–503.
   PubMedGoogle Scholar
• Purcell P, Jary H, Perry A, et al. Polymicrobial airway bacterial communities in adult bronchiectasis patients. BMC Microbiol. 2014 May;14:130.
   PubMed Web of Science ®Google Scholar
• Richardson H, Dicker AJ, Barclay H, et al. The microbiome in bronchiectasis. Eur Respir Rev. 2019 Sep;28:153.
   Web of Science ®Google Scholar
• Smith AH, Chalmers JD. The microbiome in bronchiectasis: cutting a lung story short. Respirology. 2020 01;25(1):43–44.
   PubMed Web of Science ®Google Scholar
• Oriano M, Gramegna A, Terranova L, et al. Sputum neutrophil elastase associates with microbiota and. Eur Respir J. 2020 Oct;56:4.
   Web of Science ®Google Scholar
• Flume PA, Chalmers JD, Olivier KN. Advances in bronchiectasis: endotyping, genetics, microbiome, and disease heterogeneity. Lancet. 2018 09;392(10150):880–890.
   PubMed Web of Science ®Google Scholar